A Common Heart Drug Taken by Millions May Often Be Useless – or Even Risky : ScienceAlertSeptember 3, 2025
Macrocyclic peptide start-up scores $1.5 billion deal with ArgenxBy adminJuly 1, 20251 Credit: Unnatural Products Cameron Pye is the cofounder and CEO of Unnatural Products. The biopharma company Argenx has tapped the…
